Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence

Intravesikal Instillation af Botulinum Toxin Type A Til Patienter Med Urge Urininkontinens

Status

UNKNOWN

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00770406

Enrollment

Registered

2008-10-10

Start date

2009-01-31

Completion date

2010-06-30

Last updated

2009-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urge Urinary Incontinence

Brief summary

A pilot study to examine efficacy and safety of intravesical botulinum toxin type A.

Interventions

DRUGbotulinum toxin type A

100 or 200 units intravesically

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* refractory urge urinary incontinence

Exclusion criteria

* neurological disease * pregnant or lactating * bladder neoplasias

Design outcomes

Primary

Measure	Time frame
Incontinence episode frequency	1 year

Countries

Denmark

Contacts

Primary ContactSoren Brostrom, MD, PhD

soren@brostrom.dk+45-43232243

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026